These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 23243267

  • 1. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
    Hofer J, Janecke AR, Zimmerhackl LB, Riedl M, Rosales A, Giner T, Cortina G, Haindl CJ, Petzelberger B, Pawlik M, Jeller V, Vester U, Gadner B, van Husen M, Moritz ML, Würzner R, Jungraithmayr T, German-Austrian HUS Study Group.
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):407-15. PubMed ID: 23243267
    [Abstract] [Full Text] [Related]

  • 2. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
    Lee BH, Kwak SH, Shin JI, Lee SH, Choi HJ, Kang HG, Ha IS, Lee JS, Dragon-Durey MA, Choi Y, Cheong HI.
    Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976
    [Abstract] [Full Text] [Related]

  • 3. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C, Martínez-Barricarte R, López-Trascasa M, de Córdoba SR, Sánchez-Corral P.
    Blood; 2009 Nov 05; 114(19):4261-71. PubMed ID: 19745068
    [Abstract] [Full Text] [Related]

  • 4. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
    Moore I, Strain L, Pappworth I, Kavanagh D, Barlow PN, Herbert AP, Schmidt CQ, Staniforth SJ, Holmes LV, Ward R, Morgan L, Goodship TH, Marchbank KJ.
    Blood; 2010 Jan 14; 115(2):379-87. PubMed ID: 19861685
    [Abstract] [Full Text] [Related]

  • 5. Clinical and Genetic Characteristics of Atypical Hemolytic Uremic Syndrome in Children: A Chinese Cohort Study.
    Wu D, Chen J, Ling C, Chen Z, Fan J, Sun Q, Meng Q, Liu X.
    Nephron; 2021 Jan 14; 145(4):415-427. PubMed ID: 33873197
    [Abstract] [Full Text] [Related]

  • 6. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.
    Józsi M, Licht C, Strobel S, Zipfel SL, Richter H, Heinen S, Zipfel PF, Skerka C.
    Blood; 2008 Feb 01; 111(3):1512-4. PubMed ID: 18006700
    [Abstract] [Full Text] [Related]

  • 7. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome.
    Dragon-Durey MA, Blanc C, Marliot F, Loirat C, Blouin J, Sautes-Fridman C, Fridman WH, Frémeaux-Bacchi V.
    J Med Genet; 2009 Jul 01; 46(7):447-50. PubMed ID: 19435718
    [Abstract] [Full Text] [Related]

  • 8. Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T.
    Waters AM, Pappworth I, Marchbank K, Bockenhauer D, Tullus K, Pickering MC, Strain L, Sebire N, Shroff R, Marks SD, Goodship TH, Rees L.
    Am J Transplant; 2010 Jan 01; 10(1):168-72. PubMed ID: 19951285
    [Abstract] [Full Text] [Related]

  • 9. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.
    Valoti E, Alberti M, Tortajada A, Garcia-Fernandez J, Gastoldi S, Besso L, Bresin E, Remuzzi G, Rodriguez de Cordoba S, Noris M.
    J Am Soc Nephrol; 2015 Jan 01; 26(1):209-19. PubMed ID: 24904082
    [Abstract] [Full Text] [Related]

  • 10. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.
    Boyer O, Balzamo E, Charbit M, Biebuyck-Gougé N, Salomon R, Dragon-Durey MA, Frémeaux-Bacchi V, Niaudet P.
    Am J Kidney Dis; 2010 May 01; 55(5):923-7. PubMed ID: 20202729
    [Abstract] [Full Text] [Related]

  • 11. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
    Bhattacharjee A, Reuter S, Trojnár E, Kolodziejczyk R, Seeberger H, Hyvärinen S, Uzonyi B, Szilágyi Á, Prohászka Z, Goldman A, Józsi M, Jokiranta TS.
    J Biol Chem; 2015 Apr 10; 290(15):9500-10. PubMed ID: 25659429
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Case report: A family of atypical hemolytic uremic syndrome involving a CFH::CFHR1 fusion gene and CFHR3-1-4-2 gene duplication.
    Tasaki Y, Tsujimoto H, Yokoyama T, Sugimoto N, Kitajima S, Fujii H, Hidaka Y, Kato N, Maruyama S, Inoue N, Wada T.
    Front Immunol; 2024 Apr 10; 15():1360855. PubMed ID: 38524137
    [Abstract] [Full Text] [Related]

  • 14. Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome.
    Strobel S, Abarrategui-Garrido C, Fariza-Requejo E, Seeberger H, Sánchez-Corral P, Józsi M.
    Kidney Int; 2011 Aug 10; 80(4):397-404. PubMed ID: 21677636
    [Abstract] [Full Text] [Related]

  • 15. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.
    Zipfel PF, Edey M, Heinen S, Józsi M, Richter H, Misselwitz J, Hoppe B, Routledge D, Strain L, Hughes AE, Goodship JA, Licht C, Goodship TH, Skerka C.
    PLoS Genet; 2007 Mar 16; 3(3):e41. PubMed ID: 17367211
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.
    Grenda R, Jarmużek W, Rubik J, Prokurat S, Miklaszewska M, Drozdz D, Zachwieja K, Ardissino G, Hofer J.
    Pediatr Transplant; 2015 Sep 16; 19(6):E130-4. PubMed ID: 26087050
    [Abstract] [Full Text] [Related]

  • 18. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.
    Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G.
    Clin J Am Soc Nephrol; 2010 Oct 16; 5(10):1844-59. PubMed ID: 20595690
    [Abstract] [Full Text] [Related]

  • 19. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
    Valoti E, Alberti M, Iatropoulos P, Piras R, Mele C, Breno M, Cremaschi A, Bresin E, Donadelli R, Alizzi S, Amoroso A, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2019 Oct 16; 10():853. PubMed ID: 31118930
    [Abstract] [Full Text] [Related]

  • 20. A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome.
    Eyler SJ, Meyer NC, Zhang Y, Xiao X, Nester CM, Smith RJ.
    Pediatr Nephrol; 2013 Nov 16; 28(11):2221-5. PubMed ID: 23880784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.